Docetaxel and zoledronic acid combination administered in two different sequences in hormone refractory prostate cancer patients: Phase I clinical study – ZANTE
Titel:
Docetaxel and zoledronic acid combination administered in two different sequences in hormone refractory prostate cancer patients: Phase I clinical study – ZANTE
Auteur:
Facchini, G. Caraglia, M. Morabito, A. Bruni, S.G. Nasti, G. Maiolino, P. Striano, S. Budillon, A. Di Napoli, A. Marra, M. Pisano, C. Pignata, S. Perrone, F. Iaffaioli, R.V.